Vnitr Lek 2016, 62(3):215-217

What is the significance of the phenomenon of hypertension in disguise in patients with type 2 diabetes mellitus treated for long-lasting hypertension?

Jiří Charvát
Interní klinika 2. LF UK a FN Motol, Praha

"Hypertension in disguise" is quite frequent in the patients with diabetes mellitus. It leads to organ damage similarly as persistent hypertension and it is associated with an increased cardiovascular risk which can be reduced through effective treatment. Persistent hypertension is present in 70% of the patients with type 2 diabetes mellitus. During its treatment, the picture of "masked hypertension" may be imitated (normalized blood pressure taken at a day clinic, as opposed to the increased values outside of it). This finding occurs in 35-60 % of the patients with type 2 diabetes mellitus and it is associated with the significance of changes to internal organs. The importance of this finding has been under discussion.

Keywords: type 2 diabetes mellitus; cardiovascular risk; masked hypertension

Received: February 14, 2016; Accepted: March 18, 2016; Published: March 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Charvát J. What is the significance of the phenomenon of hypertension in disguise in patients with type 2 diabetes mellitus treated for long-lasting hypertension? Vnitr Lek. 2016;62(3):215-217.
Download citation

References

  1. Sowers JR. Treatment of hypertension in patients with diabetes. Arch Intern Med 2004; 164(17): 1850-1857. Go to original source... Go to PubMed...
  2. Cífková R. Léčba hypertenze u pacientů s diabetem. Farmakoterapie 2008; 4(3): 303-308.
  3. Souček M. Hypertenze u pacienta s diabetes mellitus. Vnitř Lék 2010; 56(9 Suppl): 995-999. Go to PubMed...
  4. Pickering TG, Davidson K, Gerin W et al. Masked hypertension. Hypertension 2002; 40(6): 795-796. Go to original source... Go to PubMed...
  5. Bobrie G, Clerson P, Menard J et al. Masked hypertension: a systematic review. J Hypertension 2008; 26(9): 1715-1725. Go to original source... Go to PubMed...
  6. Chobanian AV, Bakris GL, Black H et al. The seventh Report of the Joint National Comittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289(19): 2560-2572. Go to original source... Go to PubMed...
  7. Ohkubo T, Imai Y, Tsuji I et al. Home blood measurement has stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama. J Hypertension 1998; 16(7): 971-975. Go to original source... Go to PubMed...
  8. Palatini P, Winnicki M, Snatonastaso M et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension 2004; 44(2): 170-174. Go to original source... Go to PubMed...
  9. Hanninem MR, Niiranen TJ, Puukka PJ et al. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertension 2011; 29(10): 1880-1888. Go to original source... Go to PubMed...
  10. Franklin SS, Thijs L, Li Y et al. Masked hypertension in diabetes mellitus. Treatment Implications and Clinical Practice. Hypertension 2013; 61(5): 964-971. Go to original source... Go to PubMed...
  11. Uzu T, Nakao K, Kume S et al. High Sodium Intake is associated with masked hypertension in Japanese patients with Type 2 Diabetes and Treated Hypertension. Am J Hyperten 2012; 25(11): 1170-1174. Go to original source... Go to PubMed...
  12. Charvát J, Chlumský J, Szabo M et al. The association of masked hypertension in treated type 2 diabetes patients with carotid artery IMT. Diab Res Clin Pract 2010; 89(3): 239-242. Go to original source... Go to PubMed...
  13. Leiria LF, Severo MD, Ledur PS et al. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients. Prevalence and target organ damage. J Diabetes 2015; 7(5): 699-707. Go to original source... Go to PubMed...
  14. Cushman WC, Evans GW, Byington RP et al. Effects of intensive blood-pressure control in Type 2 Diabetes Mellitus. N Engl J Med 2010; 362(17): 1575-1585. Go to original source... Go to PubMed...
  15. Cooper-De Hoff RM, Gong Y, Handberg EM et al. Tight Blood Pressure Control and Cardiovascular Outcome Among Hypertensive Patients with Diabetes and Coronary Artery Disease. JAMA 2010; 304(1): 61-68. Go to original source... Go to PubMed...
  16. UKPDS SG: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38: UK Prospective Diabetes Study Group. BMJ 1998; 317(7160): 703-713. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.